Quidel | QDEL - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 9M 2026-03
Avanos Medical USD 782.1M 625.97M 2026-03
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 875.93M 42.48M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Haemonetics USD 134.99M 1.26M 2025-12
Illumina USD 852M 51M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Merit Medical Systems USD 337.72M 2.02M 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
Neogen USD 214.5M 15.57M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quidel USD 1.85B 1.09B 2026-03
Revvity USD 628.34M 2.12M 2026-03
STAAR Surgical USD 76.12M 7.38M 2026-03
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Waters USD 1.12B 457.15M 2026-03